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Abstract
Background: Existent biomechanical studies on hip osteoarthritic gait have primarily focused on the end stage of
disease. Consequently, there is no clear consensus on which specific gait parameters are of most relevance for hip
osteoarthritis patients with mild to moderate symptoms. The purpose of this study was to explore sagittal plane
gait characteristics during the stance phase of gait in hip osteoarthritis patients not eligible for hip replacement
surgery. First, compared to healthy controls, and second, when categorized into two subgroups of radiographic
severity defined from a minimal joint space of ≤/>2 mm.
Methods: Sagittal plane kinematics and kinetics of the hip, knee and ankle joint were calculated for total joint
excursion throughout the stance phase, as well as from the specific events initial contact, midstance, peak hip
extension and toe-off following 3D gait analysis. In addition, the Western Ontario and McMaster Universities
Osteoarthritis Index, passive hip range of motion, and isokinetic muscle strength of hip and knee flexion and
extension were included as secondary outcomes. Data were checked for normality and differences evaluated with
the independent Student’s t-test, Welch’s t-test and the independent Mann–Whitney U-test. A binary logistic
regression model was used in order to control for velocity in key variables.
Results: Fourty-eight hip osteoarthritis patients and 22 controls were included in the final material. The patients
walked significantly slower than the controls (p=0.002), revealed significantly reduced joint excursions of the hip
(p<0.001) and knee (p=0.011), and a reduced hip flexion moment at midstance and peak hip extension (p<0.001).
Differences were primarily manifested during the latter 50% of stance, and were persistent when controlling for
velocity. Subgroup analyses of patients with minimal joint space ≤/>2 mm suggested that the observed deviations
were more pronounced in patients with greater radiographic severity. The biomechanical differences were,
however, not reflected in self-reported symptoms or function.
Conclusions: Reduced gait velocity, reduced sagittal plane joint excursion, and a reduced hip flexion moment in
the late stance phase of gait were found to be evident already in hip osteoarthritis patients with mild to moderate
symptoms, not eligible for total hip replacement. Consequently, these variables should be considered as key
features in studies regarding hip osteoarthritic gait at all stages of disease. Subgroup analyses of patients with
different levels of radiographic OA further generated the hypothesis that the observed characteristics were more
pronounced in patients with a minimal joint space ≤2 mm.
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Background
As the hip is crucial for locomotion [1,2], hip osteoarth-
ritis (OA) is one of the leading causes for gait impair-
ments in the elderly population [3-5]. Research on
biomechanics during gait in hip OA has, however, up
until now focused on the end-stage of disease [6], with
the vast majority of existent studies describing gait char-
acteristics before and after total hip replacement (THR)
[7-17]. Overall, there is consistency in reporting that hip
OA patients reveal some form of gait alterations. The
most frequently reported deviations are reduced stride
length and reduced cadence, reduced gait velocity, and
reduced joint excursion; in particular reduced hip exten-
sion in the sagittal plane [18-24]. However, a recent
meta-analysis by Ewen et al. [18] underlined that gait
analyses on hip OA have not been conducted in a con-
sistent manner. Including seven articles; a total of 46 dif-
ferent biomechanical variables were reported. This
illustrates the lack of a clear consensus on which specific
gait parameters should be regarded as being of most
relevance for patients with hip OA [19,25,26]. Conse-
quently, the role of gait biomechanics in hip OA initi-
ation and progression is not fully understood. For
patients with early stage hip OA, the number of studies
is far less [27,28], emphasizing this challenge even more.
However, as it has been argued that adequate exercise
and muscular strengthening can contribute to reduce
abnormal joint loading in hip OA, and, hence, impede
disease progression [29], early identification of deviant
gait characteristics is crucial in order to develop targeted
rehabilitation interventions for patients with hip OA.
The main aim of the present study was to explore sa-
gittal plane gait characteristics in subjects with hip OA
with mild to moderate symptoms compared to healthy
controls. We hypothesized that the hip OA patients
would reveal reduced hip excursion during stance, and a
reduced gait velocity compared to the healthy subjects.
As a secondary analysis, we wanted to explore potential
differences in gait between the hip OA patients when
categorized into two subgroups based on their level of
radiographic OA (ROA) severity. Pain is recognized as a
cardinal symptom of hip OA [30-32], but self-reported
symptoms are not always well associated with the degree
of joint degeneration [1,33]. Thus, we wanted to investi-
gate whether there were differences in biomechanical
characteristics between patients with different levels of
ROA. Jacobsen and colleagues [34] found a minimal
joint space (MJS) of ≤2 mm to be the radiographic cri-
terion most strongly associated to self-reported hip pain.
Furthermore, ≤2 mm MJS is the established cut-off used
by the orthopedic surgeons at our clinic when categoriz-
ing patients with hip OA from their level of radiographic
progression. Therefore, we pre-defined MJS ≤2 mm and
>2 mm as cut-offs for the subgroups, and hypothesized
that the patients with more severe ROA would reveal
reduced hip excursion during stance, and also reduced
gait velocity compared to those with less severe ROA.
As the novelty of this study entailed an explorative
approach, we included The Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
subscales for pain, function and stiffness, clinically
assessed range of motion (ROM) of the hip joint, and
isokinetic muscle strength of the extensor and flexor
muscles of the hip and knee joints as secondary assess-
ments to describe the level of symptoms and function of
the subjects included in our material.
Material and methods
Subjects
This study was a biomechanical substudy from a larger
randomized controlled trial (RCT) (www.clinicaltrials.
gov; reference number NCT00319423) where 109
patients with hip OA with mild to moderate pain were
included [35]. The aim of the overall RCT was to eva-
luate the efficacy of adding an exercise program to patient
education, with WOMAC pain as primary outcome. The
present material involved a convenience sample of the first
53 patients included in the RCT, who in addition to cli-
nical and functional assessments also went through a data
collection with biomechanical 3D motion analysis. Motion
analyses were in addition conducted for 26 healthy con-
trols. As all the patients were referred to baseline gait ana-
lyses before they were allocated to randomization, this
substudy had a cross-sectional design. A flow-chart of the
material in relation to the overall RCT is shown in
Figure 1.
Patients were recruited from two hospitals, one sports
medicine and rehabilitation center, and from family
physician clinics. Patients between 40 and 80 years with
uni- or bilateral hip pain for at least three months were
eligible for inclusion. Subjects who agreed to participate
were examined according to the Harris Hip Score (HHS)
[36], and assessed by the same physical therapist (LF).
As a HHS score <60 is used as a cut-off for THR at our
institution [37], and >95 reflects normal function, a
HHS score range from 60–95 was interpreted to reflect
mild to moderate symptoms and set as an inclusion cri-
terion. The main HHS-score of the included patients
was 78.2 (SD 8.2). Subjects were further assessed with
radiographs, and hip ROA was verified following
Danielsson’s criteria [38]. For subjects with bilateral in-
volvement, the most painful hip joint was defined as the
target joint. Previous THR, recent trauma and/or injury
involving the lower limb, rheumatoid arthritis, cancer,
heart disease, osteoporosis, low back pain or knee pain
led to exclusion from the study. The controls were
recruited through acquaintances of the included
patients, and of colleagues at our institution. To be
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included, controls had to be within the same age limits,
have a HHS score ≥96 and withstand the same exclusion
criteria as the hip OA patients. All participants signed
an informed consent before inclusion. The study was
approved by the Regional Medical Research Ethics Com-
mittee of Eastern Norway, and conducted in accordance
with the Helsinki Declaration.
Outcome measurements
Gait analysis
Gait analyses took place in the Motion Analysis Labora-
tory at The Norwegian School of Sports Sciences. Kine-
matic data was collected using a Qualisys pro-reflex
motion analysis system (Qualisys AB, Gothenburg,
Sweden) with eight cameras at a sampling frequency of
240 Hz, synchronized with three AMTI LG6 force plates
(Advanced Mechanical Technology Inc, Watertown,
MA, US) sampling kinetic data at a rate of 960 Hz.
Reflective passive anatomical markers defining the joint
centers were placed over the medial and lateral malleolus,
medial and lateral femoral condyle, bilaterally over the
greater trochanter, and bilaterally on the top iliac crest.
Further, three rigidly attached reflective passive markers
placed on thermoplastic shells were located at the
sacrum, and bilaterally at the thigh and shank. Both feet
were defined by two markers attached to the heel of
the shoe and one marker at the 5th metatarsal head.
Subjects were instructed to look straight forward and
walk at their self-selected speed along a 17 meter walk-
way, in which the force plates were embedded. Self-
selected walking speed has been shown to be preferable
in order to reduce the variability of gait [39]. Velocity
was measured by photoelectric beams located 3.06 m
apart, midway along the walkway. Data collection was
continued until 12 acceptable hits for each limb on the
force plates were captured. As 5–10 trials have been sug-
gested to assure adequate reliability and prevail inherent
variability in gait analyses in patients with hip OA [40],
we selected the 6–8 trials of the 12 captured that were
free from artifacts and within +/− 5% of the average
velocity for analyses. Data were processed with Visual 3D
software (C-motion Inc, Crabbs Branch Way Rockville
MD), a movement analysis program which calculates
the six degrees of freedom of a link rigid segment in an
inertial reference system and uses that information to
compute joint kinematics and kinetics. The following
events were defined during the stance phase of gait:
Initial contact (threshold 25 N), midstance (identified as
the midpoint temporal observation of the stance phase
when normalized from 0-100%), peak hip extension
(peak hip extension angle) and toe-off (threshold 25 N).
Ten of the 48 patients that were included in the final
analyses had bilateral involvement. There were no sig-
nificant systematic differences between these patients
and the patients with unilateral involvement on any of
the outcome variables (p>0.05). Thus, only the limb with
the target hip joint of the patients was included in the
analyses. Further, there were no systematic differences
between the right and the left limb of the controls
(p>0.05). Therefore, the left limb was drawn to be
included as control limb. Total sagittal plane joint excur-
sion of the hip, knee and ankle joint was calculated
Hip OA patients included in main  
RCT from April 2005 to September 
2007 (n=109)
Controls (n=26)
Not asked to participate in gait 
analysis: Patients recruited the last  
year of inclusion (n=56) 
Hip OA patients (n=53)
Excluded from analysis due to previous 
THR on the contralateral side (n=4) 
and inadequate data (n=1)
Hip OA patients included in final 
analysis (n=48)
Controls included in final 
analysis (n=22)
Excluded from analysis due to  
technical problems and 
inadequate data (n=4)
3D gait analyses, WOMAC, 
isokinetic muscle strength, ROM 
and radiographic assessment
3D gait analyses, isokinetic 
muscle strength and ROM
Asked to participate in gait  
analysis: Patients recruited the 
first 18 months of inclusion (n=53)
BIOMECHANICAL SUBSTUDY
Figure 1 Flow-chart of the material included in the study.
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throughout the stance phase of gait, as well as joint
angles (°) and joint moments given as external moments
in Newton-meters normalized to bodyweight in kilo-
grams (Nm/BW) for the hip, knee and ankle joint at the
four defined events.
Radiographic assessment
MJS of the target joint was measured on standardized
postero-anterior digital pelvic radiographs (Syngo Ima-
ging V36, Siemens AG, Erlangen, Germany) centered on
the symphysis. Assessment of the MJS have shown to be
a valid approach in diagnosing hip OA [2]. All radio-
graphs were evaluated by one orthopedic surgeon (LN).
The shortest distance between subchondral bone in the
femoral head and in the acetabulum was identified vi-
sually, and the distance to the femoral surface measured
in millimeters (mm).
Functional and clinical assessments
The WOMAC pain, stiffness and function subscales
were included for the hip OA patients only. The patients
evaluated their status on a 100 mm visual analogue
scale, with 0 as anchor to no pain/stiffness/difficulty,
and 100 as anchor to extreme pain/stiffness/difficulty
[41]. For both patients and controls, hip ROM (°) in ex-
tension, flexion, abduction, adduction, internal rotation
and external rotation was measured with a half-circle 1°-
increment plastic goniometer. Finally, isokinetic muscle
strength of the hip and knee joint extensors and flexors
was evaluated from five repetitions at a velocity of 60°
per second with a REV 9000 isokinetic dynamometer
(Technogym, SpA, Gamboletta, Italy). The single highest
achieved peak torque normalized to bodyweight (Nm/
kilograms*100) was used as outcome measure. Detailed
procedures for ROM and isokinetic muscle strength mea-
surements have previously been described by Rydevik
et al. [37].
Analysis
Analyses were done in SPSS 18.0 (SPSS Inc., Chicago,
IL, US). All data were checked for normality with the
Shapiro-Wilk test and Q-Q plots. To compare differ-
ences between patients and controls, and further be-
tween patients with MJS ≤/>2 mm, normally distributed
variables were first assessed from the Levene’s test to de-
cide whether p-values should be reported based on
equality of variances with a Student’s t-test or non-
equality with a Welch’s t-test. Non-normally distributed
variables were evaluated with the independent Mann–
Whitney U-test. Finally, binary logistic regression models
with velocity as the predictor variable and key variables
identified to be deviant between the hip OA patients and
controls as dependent variables were calculated in order
to control for velocity. Level of statistical significance
was set to p<0.05.
Results
Fourty-eight patients and 22 controls were included in
the final analyses. The patients consisted of 19 men and
29 women, and the controls of 9 men and 13 women.
The subject characteristics and secondary assessments
describing level of symptoms and function for the over-
all group of hip OA patients and controls are presented
in Table 1. No differences were found in anthropometric
measures, but as expected the hip OA patients had sig-
nificantly reduced hip ROM (p<0.001 to 0.001) in all
directions except adduction. Reductions were most
prominent in flexion (17.1°), internal rotation (15.3°),
and external rotation (20.2°). Further, their knee extensor
muscle strength was 33.5 Nm/BW lower compared to
the controls (p=0.001).
The hip, knee and ankle joint angles from initial con-
tact to toe-off, and the corresponding joint moments,
are shown in Figures 2 and 3, respectively. The figures
include comparisons of both the overall group of
patients versus controls, and between patients with MJS
≤/>2 mm.
Patients with hip OA walked significantly slower
(p=0.002) than the controls, with a velocity of 1.53 (SD
0.2) compared to 1.65 (SD 0.2) meter per second. Statis-
tical comparisons of joint excursion throughout stance,
as well as specific angles and moments at the four
defined events, are shown for the overall group of
patients and controls in Table 2.
With regard to kinematics, hip and knee joint excur-
sion was reduced by 10.0° (p<0.001) and 4.3° degrees
(p=0.011), respectively. When adjusted for velocity, hip
excursion was still significantly reduced (p=0.008),
whereas knee excursion was not (p=0.161). Analyses at
the specified events revealed that the observed differ-
ences in excursion stem from the latter 50% of the
stance phase, where hip and knee joint extension was
significantly reduced with 7.6° to 9.6° for the hip, and
3.9° to 9.0° for the knee (p-values from <0.001 to 0.009).
The reduced kinematic hip extension was reflected in
the kinetics, in that hip OA patients had a significantly
reduced hip flexion moment at mid-stance with a mean
difference of −0.082 Nm/BW, and at peak hip extension
with a mean difference of −0.176 Nm/BW (both
p<0.001). When controlled for velocity, these differences
were still evident (p=0.015 and p=0.004, respectively).
There were no differences in knee moments, but the
plantarflexion ankle joint moment was significantly dif-
ferent with 0.008 Nm/BW, -0.054 Nm/BW and 0.105
Nm/BW at initial contact, midstance and peak hip ex-
tension, respectively (p-values 0.002 to 0.035).
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Subject characteristics for patients with MJS ≤/>2 mm
are given in Table 3. No statistical significant differences
were established from the anthropometric measures, hip
ROM, muscle strength or WOMAC; except for hip
ROM abduction which was reduced by 4.8° (p=0.026)
and adduction which was reduced by 3.8° (p=0.049) in
the group with more severe ROA.
Statistical comparisons of joint excursion throughout
stance, as well as specific angles and moments at the
four defined events for patients with MJS ≤/>2 mm are
shown in Table 4.
No difference (p=0.223) was found in gait velocity.
Patients with MJS ≤2 mm revealed a 4.5° reduced hip
excursion (p=0.046) compared to patients with MJS>2
mm. When adjusted for velocity, the difference was no
longer significant (p=0.130). No significant kinematic
differences were established for the hip joint at the spe-
cific events. Extension was significantly reduced only for
the knee joint at midstance, with 2.9° (p=0.021), and at
peak hip extension with 5.7° (p=0.016). The hip flexion
moment at peak hip extension was, however, signifi-
cantly lower in patients with MJS ≤2 mm, with a mean
difference of −0.117 Nm/BW (p<0.001). This difference
was persistent after controlling for velocity (p=0.028).
No differences were established for knee- or ankle
moments.
Discussion
The main findings of this study were that compared to
controls, patients with hip OA with mild to moderate
symptoms walked with significantly reduced velocity,
and revealed significantly reduced hip and knee joint ex-
cursion, specifically manifested as reduced extension in
the hip and knee joint during the latter 50% of the
stance phase. Thus, our hypothesis that hip OA patients
in this early stage of disease would reveal reduced hip
excursion during stance and a reduced gait velocity com-
pared to healthy subjects was confirmed. Our secondary
hypothesis, that hip OA patients with severe ROA
defined from a MJS ≤2 mm would reveal reduced hip
Table 1 Subject characteristics and hip function assessments; hip osteoarthritis patients and controls
HIP OA PATIENTS
(n=48)
CONTROLS
(n=22)
MEAN DIFFERENCE
(95% CI)
P-VALUE
(TEST USED)
Mean SD Mean SD
Age (years) 59.1 9.48 58.5 8.79 0.6 (−4.21 to 5.33) 0.813(□)
Height (cm) 172.3 8.36 171.7 10.81 0.6 (−0.04 to 0.05) 0.811(□)
Weight (kg) 73.2 12.21 70.8 15.13 2.4 (−4.38 to 9.17) 0.483(□)
Body Mass Index 24.6 3.33 23.8 3.46 0.8 (−0.98 to 2.48) 0.388(□)
Target joint MJSa 1.9 1.05
Harris Hip Score 78.2 8.15 99.5 1.19 −21.3 (−24.73 to −17.76) <0.001(□)
WOMACb
WOMAC function 22.4 16.38
WOMAC stiffness 32.1 22.92
WOMAC pain 25.3 18.07
Hip range of motion (°)
Flexion 121.2 17.49 138.3 7.77 −17.1 (−25.16 to −8,86) <0.001(◊)
Extension 0.8 8.56 9.9 5.15 −9.1(−13.00 to −4.78) <0.001(◊)
Abduction 23.0 10.08 31.4 6.19 −8.4 (−12.60 to −2.90) <0.001(○)
Adduction 23.5 7.48 25.4 5.39 −1.9 (−5.85 to 1.43) 0.317(○)
Internal rotation 31.4 15.01 46.7 11.74 −15.3 (−21.69 to −6.58) 0.001(○)
External rotation 24.3 12.91 44.5 7.49 −20.2 (−26.75 to −14.41) <0.001(◊)
Muscle strength (Nm/BW*100c)
Hip flexion 120.7 36.65 135.3 31.95 −14.6 (−33.40 to 4.20) 0.126(□)
Hip extension 197.2 68.96 223.4 57.35 −26.2 (−61.17 to 8.80) 0.140(□)
Knee flexion 87.7 27.96 98.3 25.18 −10.6 (−25.09 to 3.89) 0.149(□)
Knee extension 143.6 36.17 177.1 34.01 −33.5 (−52.47 to −14.56) 0.001(□)
a: Minimal joint space.
b: The Western Ontario and McMaster Universities Osteoarthritis Index.
c: Newton meter/body weight*100.
□: Student’s t-test.
◊: Welch’s t-test.
○: Mann–Whitney U-test.
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excursion during stance and reduced gait velocity com-
pared to patients with MJS >2 mm, was only partly con-
firmed; as these patients had significantly reduced hip
excursion during stance, but no difference in gait
velocity.
The rationale for this study was the lack of consensus
on the identification of specific gait parameters in
patients with hip OA, especially with regard to patients
in the early stage of disease. The included patients in
this study had a mean (SD) HHS score of 78.2 (8.2), de-
fining them as non-eligible for THR in our institution,
and a mean (SD) WOMAC pain subscore of 25.3 (18.1),
reflecting mild to moderate pain [42]. In our clinic, the
orthopedic surgeons use ≤2 mm MJS as their clinically
anchored cut-off when categorizing patients with hip
OA from their level of radiographic progression. We
therefore defined this as the cut-off value for subcatego-
rizing our cohort. There is no absolute consensus on
categorizing radiographic severity based on MJS in hip
OA. However, several studies state ≤2.5 mm MJS as a
minimum for defined ROA, and a MJS ≤1.5 mm as se-
vere ROA [1,2,43-45]. Reijman and colleagues [46] more
explicitly suggest MJS ≤2.5 mm as intermediate, ≤2 mm
as moderate and ≤1.5 mm as severe ROA, respectively.
The hip OA patients included in this study were, thus,
overall ratified to having a mild to moderate level of dis-
ease, assessed both from symptoms and radiographs;
and the subjects classified to have more severe ROA as
having at least moderate radiographic changes.
The identification of reduced velocity and reduced hip
and knee joint extension during the latter 50% of the
stance phase as key gait features in our cohort, con-
firmed that the biomechanical deviations most com-
monly described in severe hip OA gait are manifest
already at an early stage of disease. To our knowledge,
no more than two other studies [27,28] have reported
3D gait analysis data of patients at a comparable stage of
hip OA, and also compared them to controls. Of these,
only the study by Dujardin and colleagues [27] had a
sample size comparable to ours. Unfortunately, their
study was published in French, so we were unable to
weigh our findings against theirs. In line with our
findings, the other study by Watelain et al. [28] iden-
tified reduced velocity and reduced hip excursion as
Figure 2 Joint excursion angles (°) of the hip, knee and ankle during stance phase of gait.
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characteristics of gait in patients with early stage hip OA.
However, their sample size was considerably smaller than
ours. Thus, our study adds clinically relevant knowledge
on biomechanics during gait in a population of hip OA
patients that previously has been given little attention.
Our hip OA patients walked with significantly reduced
velocity compared to the controls. Still, their walking
speed was faster than what have commonly been
reported, compared both to age-related normative data
[47,48] and studies including patients with severe hip
OA [12,49]. A plausible cause for the latter is the fact
that we included patients with mild to moderate symp-
toms, in contrast to most studies that have focused on
patients in the end-stage of disease. Higher walking ve-
locity has been shown to increase joint moments [50]
and accentuate pathological changes in patients with se-
vere hip OA [51]. Thus, it can be questioned whether
observed biomechanical changes in hip OA patients can
be explained merely from their reduced gait speed. How-
ever, reduced velocity appears inherently linked to dis-
ease progression, and can as such be regarded to be an
intrinsic key feature of hip OA gait. Thus, it is not
straightforward to consider velocity solely as a “disturb-
ing” variable, that should be controlled for in a regular
analysis of variance, leaving the unadjusted analyses out
[26]. From a clinical perspective, controlling for velocity
can give diminutive meaning; as it is inapplicable to just
tell the patients to walk faster in order to reduce their
joint moments. For these reasons, we performed the
main analyses unadjusted for velocity; but included a
supplementary binary logistic regression model to reveal
whether the observed key differences in hip and knee ex-
cursion and hip joint moments were persistent after
adjusting for velocity. These analyses confirmed that the
reductions in hip excursion and hip joint moments in
hip OA patients compared to controls were persistent
regardless of velocity; whereas knee excursion was not.
The unadjusted and adjusted analyses together thus
strengthened the identification of reduced hip extension
during excursion and hip flexion moments as key fea-
tures of gait in hip OA patients with mild to moderate
symptoms.
Figure 3 External joint moments (Nm/BW) for the hip, knee and ankle during stance phase of gait.
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Table 2 Sagittal plane gait characteristics of all hip osteoarthritis patients and controls
HIP OA PATIENTS
(n=48)
CONTROLS
(n=22)
MEAN DIFFERENCE
(95% CI)
P-VALUE
(TEST USED)
Mean SD Mean SD
GAIT VELOCITY (m/sec) 1.53 0.146 1.65 0.150 −0.12 (−0.197 to −0.045) 0.002(□)
KINEMATIC PARAMETERS (°)
Hip excursion 37.4 7.78 47.4 6.22 −10.0 (−13.79 to −6.25) <0.001(□)
Knee excursion 41.2 6.08 36.9 7.07 4.3 (1.02 to 7.60) 0.011(□)
Ankle excursion 19.9 3.83 19.0 7.62 0.9 (−1.84 to 3.61) 0.519(□)
Initial contact
Hip joint angle 29.1 5.15 29.5 7.43 −0.4 (−3.45 to 2.67) 0.825(◊)
Knee joint angle 3.0 3.86 3.5 3.91 −0.5 (−2.43 to 1.56) 0.669(□)
Ankle joint angle 0.4 3.19 0.9 3.69 −0.5 (−2.18 to 1.28) 0.604(□)
Midstance
Hip joint angle 6.4 5.29 2.4 6.78 4.0 (0.97 to 6.92) 0.021(◊)
Knee joint angle 10.9 4.31 8.5 4.33 2.4 (0.17 to 4.60) 0.035(□)
Ankle joint angle 3.9 2.85 3.1 2.95 0.9 (−0.60 to 2.36) 0.238(○)
Peak hip extension
Hip joint angle −8.3 7.61 −17.9 6.85 9.6 (5.83 to 13.42) <0.001(□)
Knee joint angle 20.5 8.22 11.5 6.04 9.0 (5.17 to 13.00) <0.001(□)
Ankle joint angle 6.6 4.34 6.1 4.15 0.5 (−1.71 to 2.69) 0.658(□)
Toe-off
Hip joint angle −2.7 6.45 −10.3 7.00 7.6 (4.17 to 10.98) <0.001(□)
Knee joint angle 44.2 5.26 40.3 6.21 3.9 (1.10 to 6.74) 0.009(□)
Ankle joint angle −13.3 4.48 −12.9 7.38 −0.4 (−3.24 to 2.45) 0.783(○)
KINETIC PARAMETERS (Nm/BWa)
Initial contact
Hip joint moment −0.202 0.0709 −0.234 0.0969 0.032 (−0.0095 to 0.0726) 0.130(○)
Knee joint moment −0.134 0.0387 −0.156 0.0396 0.019 (−0.0001 to 0.0399) 0.051(○)
Ankle joint moment −0.005 0.0127 −0.013 0.0089 0.008 (0.0017 to 0.1377) 0.002(○)
Midstance
Hip joint moment −0.105 0.0858 −0.023 0.7891 −0.082 (−0.1247 to −0.0386) <0.001(□)
Knee joint moment −0.037 0.0822 −0.020 0.0760 −0.017 (−0.5834 to 0.0244) 0.440(□)
Ankle joint moment - 0.291 0.1035 −0.237 0.0761 −0.054 (−0.1037 to −0.0051) 0.007(□)
Peak hip extension
Hip joint moment 0.284 0.1538 0.459 0.2017 −0.176 (−0.2631 to −0.0885) <0.001(□)
Knee joint moment 0.075 0.0737 0.053 0.1136 0.022 (−0.0230 to 0.0674) 0.408(◊)
Ankle joint moment −0.566 0.1584 −0.671 0.1976 0.105 (0.0173 to 0.1935) 0.035(□)
Toe-off
Hip joint moment 0.226 0.0576 0.235 0.0804 −0.005 (−0.3902 to 0.02830) 0.780(□)
Knee joint moment 0.058 0.0196 0.061 0.0279 −0.003 (−0.1486 to 0.0083) 0.621(◊)
Ankle joint moment 0.008 0.0082 0.009 0.0086 −0.001 (−0.0045 to 0.0040) 0.892(□)
a: Newton meter/body weight.
□: Student’s t-test.
◊: Welch’s t-test.
○: Mann–Whitney U-test.
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Abnormal joint loading has been shown to contribute
to detrimental shear stresses as well as disruption and
loss of cartilage, and is considered to be an important
mechanism of lower limb OA pathogenesis [52-59].
Accumulated inadequate loads may further play a role in
disease progression, as they can facilitate enlargement of
the joint surface that is worn down [29,59,60]. A rele-
vant factor in this aspect is the reduced range of passive
hip joint extension we found for the hip OA patients.
Static contractures that increase the stiffness of the hip
joint have long been suggested to limit hip extension
during the late phase of stance [23]. The hip OA
patients in our study had a mean of 0.8° (8.7) passive hip
ROM extension; a mean reduction of 9.1° compared to
the controls (p<0.001). This was reflected during gait,
where the hip OA patients had 9.6° less peak hip exten-
sion than the controls. Simonsen et al. [61] recently
reported that walking with the upper body inclined was
associated with both a significant increase in hip joint
flexion angle and a significantly reduced hip flexion
moment in the latter phase of stance. As our experimen-
tal set-up did not include an upper body model, we
could not report the positioning of the upper body in
our subjects. However, we found the exact same pattern
of both reduced hip extension angle and reduced hip
flexion moment during late stance in our cohort. The
verification of these biomechanical deviations already in
hip OA patients with mild to moderate symptoms, may
reflect an unfavorable stress distribution that possibly
can contribute to facilitated disease progression.
In correspondence with the hip joint, reduced exten-
sion during the latter 50% of the stance phase was found
also in the adjacent knee when we compared the hip OA
patients to the controls (p-values between <0.001 and
0.035). Further, a significant reduction in isokinetic knee
extension strength was established between the overall
group of patients and the controls (p=0.001). It is clinic-
ally important to be aware that such deviations will in-
fluence knee joint loading, and over time may contribute
to the development of secondary degenerative changes
Table 3 Subject characteristics and hip function assessments; hip osteoarthritis patients with MJS ≤/> 2 mm
MJSa ≤2.0 mm
(n=28)
MJSa >2.0 mm
(n=20)
MEAN DIFFERENCE
(95% CI)
P-VALUE
(TEST USED)
Mean SD Mean SD
Age (years) 60.0 9.56 57.8 9.46 2.2 (−3.42 to 7.80) 0.437(□)
Height (cm) 173.5 9.36 170.5 6.57 3.0 (−0.02 to 0.08) 0.224(◊)
Weight (kg) 75.3 12.12 70.3 12.03 5.0 (−2.12 to 12.12) 0.164(□)
Body Mass Index 24.9 3.23 24.1 3.48 0.8 (−1.14 to 2.79) 0.404(□)
Target joint MJSa 1.2 0.71 2.9 0.43 −1.7 (−2.08 to −1.37) <0.001(◊)
Harris Hip Score 77.3 8.26 79.5 8.02 −2.2 (−6.98 to 2.65) 0.370(□)
WOMACb
WOMAC pain 27.7 18.69 22.1 17.07 5.6 (−5.01 to 16.26) 0.272(○)
WOMAC function 25.9 17.96 17.5 12.76 8.4 (−1.05 to 17.83) 0.152(○)
WOMAC stiffness 34.5 23.0 28.7 22.96 5.8 (−7.78 to 19.31) 0.305(○)
HIP ROM (°)
Flexion 117.7 17.46 126.7 16.58 −9.0 (−19.01 to 1.14) 0.081(□)
Extension −0.3 7.95 2.5 9.32 −2.8 (−7.84 to 2.23) 0.267(□)
Abduction 21.5 10.68 26.3 8.69 −4.8 (−10.55 to −1.13) 0.026(○)
Adduction 21.9 7.02 25.7 7.49 −3.8 (−8.06 to −0.45) 0.049(○)
Internal rotation 28.9 14.87 35.9 14.80 −7.0 (−15.84 to 1.65) 0.094(○)
External rotation 22.0 11.65 27.5 14.17 −5.5 (−12.97 to 2.07) 0.151 □)
Muscle strength (Nm/BW*100c)
Hip flexion 118.9 43.66 123.2 24.57 −4.3 (−26.07 to 17.53) 0.669(○)
Hip extension 195.1 82.11 200.2 46.55 −5.1 (−46.20 to 35.89) 0.784(○)
Knee flexion 90.2 31.69 84.3 22.30 5.9 (−10.84 to 22.57) 0.483(○)
Knee extension 141.1 43.05 146.9 24.71 −5.8 (−27.47 to 15.85) 0.806(□)
a: Minimal joint space.
b: The Western Ontario and McMaster Universities Osteoarthritis Index.
c: Newton meter/body weight*100.
□: Student’s t-test.
◊: Welch’s t-test.
○: Mann–Whitney U-test.
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Table 4 Sagittal plane gait characteristics of hip osteoarthritis patients with MJS ≤/>2.0 mm
MJSa ≤2.0 mm
(n=28)
MJSa >2.0 mm
(n=20)
MEAN DIFFERENCE
(95% CI)
P-VALUE
(TEST USED)
Mean SD Mean SD
VELOCITY (m/sec) 1.56 0.122 1.50 0.159 −0.05 (−0.138 to 0.033) 0.223(□)
KINEMATIC PARAMETERS (°)
Hip excursion 35.5 8.03 40.0 6.76 −4.5 (−8.95 to −0.08) 0.046(□)
Knee excursion 42.5 6.26 39.3 5.40 3.3 (−0.24 to 6.74) 0.067(□)
Ankle excursion 19.3 3.48 20.7 4.20 −1.5 (−3.72 to 0.76) 0.190(□)
Initial contact
Hip joint angle 28.7 5.53 29.7 4.65 −1.0 (−4.04 to 2.07) 0.520(□)
Knee joint angle 3.2 4.17 2.8 3.48 0.4 (−1.87 to 2.73) 0.709(□)
Ankle joint angle −0.4 3.09 1.6 3.00 −2.0 (−3.83 to −0.23) 0.028(□)
Midstance
Hip joint angle 6.9 5.24 5.7 5.41 1.2 (−1.89 to 4.37) 0.431(□)
Knee joint angle 12.1 3.85 9.2 4.46 2.9 (0.46 to 5.30) 0.021(□)
Ankle joint angle 4.3 2.58 3.21 3.2 0.8 (−0.87 to 2.50) 0.336(□)
Peak hip extension
Hip joint angle −6.8 7.41 −10.3 7.60 3.5 (−0.88 to 7.94) 0.114(□)
Knee joint angle 22.9 8.34 17.2 6.94 5.7 (1.09 to 10.28) 0.016(□)
Ankle joint angle 6.4 4.11 6.8 4.76 −0.4 (−2.94 to 2.23) 0.782(□)
Toe-off
Hip joint angle −1.6 6.26 −4.3 6.55 2.7 (−1.04 to 6.5) 0.152(□)
Knee joint angle 45.7 4.81 42.1 5.22 3.6 (0.74 to 6.62) 0.015(□)
Ankle joint angle −12.8 4.97 −13.9 3.69 1.1 (−1.53 to 3.77) 0.398(□)
KINETIC PARAMETERS (Nm/BWb)
Initial contact
Hip joint moment −0.189 0.0609 −0.220 0.0813 0.031 (−0.0111 to 0.0714) 0.149(□)
Knee joint moment −0.127 0.0338 −0.147 0.0431 0.020 (−0.0036 to 0.0411) 0.098(□)
Ankle joint moment −0.004 0.0143 −0.007 0.0102 0.003 (−0.0038 to 0.0112) 0.092(○)
Midstance
Hip joint moment −0.119 0.0874 −0.083 0.0811 −0.036 (−0.8631 to 0.1371) 0.431(□)
Knee joint moment −0.037 0.0769 −0.037 0.0912 0.000 (−0.4901 to 0.4896) 0.452(○)
Ankle joint moment −0.304 0.1142 −0.274 0.0863 −0.029 (−0.0908 to 0.0311) 0.315(○)
Peak hip extension
Hip joint moment 0.235 0.1419 0.352 0.1465 −0.117 (−0.2022 to −0.0327) 0.001(○)
Knee joint moment 0.076 0.0771 0.075 0.0707 0.001 (−0.0428 to 0.4497) 0.961(□)
Ankle joint moment −0.539 0.1450 −0.601 0.1667 0.062 (−0.0307 to 0.1544) 0.186(□)
Toe-off
Hip joint moment 0.225 0.0579 0.227 0.0587 −0.002 (−0.0364 to 0.0322) 0.903(□)
Knee joint moment 0.058 0.0174 0.057 0.0227 0.001 (−0.0103 to 0.1296) 0.822(□)
Ankle joint moment 0.009 0.0087 0.007 0.0073 0.002 (−0.0029 to 0.0067) 0.432(□)
a: Minimal joint space.
b:Newton meter/body weight.
□: Student’s t-test.
◊: Welch’s t-test.
○: Mann–Whitney U-test.
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also in the knee joint. As the patients in this study were
excluded if they had any form of knee pain or dysfunc-
tion, including restrictions in passive knee ROM, the
observed differences at the knee joint are likely to be
adaptive consequences of the structural changes and
pain in the hip joint. This was further supported by the
finding that in contrast to the hip joint excursion, the
knee joint excursion difference was no longer significant
when adjusting for velocity.
To what extent the level of ROA is reflected in bio-
mechanics during gait in hip OA patients non-eligible
for THR, has never been investigated. When subcategor-
izing the hip OA patients from their level of ROA, the
patients with ≤2 mm MJS were classified as having se-
vere ROA (mean MJS of 1.2mm), and the patients with
>2 mm MJS as having intermediate ROA (mean MJS of
2.9 mm) [46]. The hip and knee kinematic joint excur-
sion curves illustrated that patients with MJS ≤2 mm
revealed the largest deviations. However, this was not
reflected in the functional or clinical assessments.
No differences were evident between patients with
MJS ≤/>2 mm in either of the WOMAC subscales. It
has been stated that ROM restrictions are larger in
patients with more severe ROA [62], but we did not find
statistical significant differences in hip ROM flexion or
extension between the two subgroups. However, the lack
of significance must be interpreted with caution, due to
the relatively low number of subjects in each group. It
cannot be ruled out that the 9° difference in hip flexion
and the 7° difference in internal rotation may be of
clinical importance. Finally, we found no differences in
isokinetic hip muscle strength. However, patients with
MJS ≤2 mm revealed a highly significant reduced hip
flexion moment at peak hip extension (p=0.001), that
still was significantly reduced when controlling for vel-
ocity (p=0.028). This may indicate non-optimal use of
the hip extensor muscles that was manifested during
walking; but not during the isokinetic test. In sum, our
findings suggested that more severe ROA resulted in
more distinct gait alterations in the sagittal plane, even
though there were no significant differences in symp-
toms or function. This emphasizes the importance of
supplementing self-reported and clinical outcome mea-
sures with assessments that quantify function and gait
[63], when trying to understand how altered gait can
influence disease progression – or vice versa.
Overall, the findings of this study are in line with pre-
vious studies suggesting reduced velocity, reduced sagit-
tal plane joint excursion and a reduced hip flexion
moment in the late stance phase as key features of hip
OA gait. What is new from our study, is that these hall-
marks are evident already in hip OA patients at an early
stage of symptoms. These patients are not eligible for
total hip replacement. Rather; they should be considered
as primary candidates for exercise therapy. In this context,
the identification of early stage gait alterations is clinically
important, as it may contribute to enable development of
targeted treatment interventions. To what extent the
observed alterations were primarily caused by – or a result
from – the level of pain, changes in bone and cartilage
morphology, muscle weakness or reduced passive ROM,
is still unknown. Thus, it remains a question whether the
gait characteristics described in this study may drive fur-
ther progression of either symptomatic or radiographic
hip OA; or primarily reflect adaptations to the constraints
posed by the degenerative changes in the joint. Hence, fu-
ture studies should investigate with particular interest the
relationship between these key biomechanical features
and different clinical and functional outcomes.
There are some limitations to this study that need to
be addressed. First, only sagittal plane gait characteristics
were reported, as we wanted to emphasize hip excursion,
and in particular hip extension, in this plane. A compre-
hensive gait analysis should however include also frontal
and transversal plane kinematics and kinetics. Further,
the included analyses between the two pre-defined sub-
groups of patients with MJS ≤/>2 mm were not statisti-
cally corrected for multiplicity. In addition, the subgroup
sample sizes were smaller. Our findings related to the
secondary aim of this study should therefore be regarded
as an explorative supplement to the main analysis, and
as such be interpreted as hypothesis-generating rather
than conclusive [64].
Conclusions
Patients with hip OA with mild to moderate symptoms
walked with reduced velocity compared to healthy con-
trols, and revealed evident alterations in the latter 50%
of the stance phase of gait. Reduced extension during
hip and knee excursion and a reduced hip flexion mo-
ment were the main characteristics. From supplementary
analyses of the two pre-defined subgroups of patients
with different levels of ROA, this study generated the
hypothesis that the observed characteristics were more
pronounced in hip OA patients with ≤2 mm MJS.
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